Citation Impact

Citing Papers

Rethinking the Optimal Duration of Immune Checkpoint Inhibitors in Non-small Cell Lung Cancer Throughout the COVID-19 Pandemic
2020
Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China
2020 Standout

Works of Vérane Achard being referenced

The Activity of Immune Checkpoint Inhibition in KRAS Mutated Non-small Cell Lung Cancer: A Single Centre Experience
2019
Rankless by CCL
2026